What makes some cancers more deadly?

April 23, 2014
What makes some cancers more deadly?
Dr Lauren Thurgood is investigating what makes a common form of leukaemia more deadly.

A Flinders University researcher is searching for answers as to why some leukaemia sufferers live a normal lifespan while others succumb to the disease within months.

Dr Lauren Thurgood, based in the Department of Haematology and Genetic Pathology, is studying a common form of leukaemia called (CLL) to better understand why a sub-group of patients with this particular type of cancer respond poorly to treatment.

Comprising about 30 per cent of all leukaemias, CLL is a slow-growing form of the disease in which the bone marrow makes too many .

"I'm looking at proteins in the cancer cells to try to work out why some patients have a more pathogenic disease while other people who have CLL live longer and don't have any problems," Dr Thurgood said.

"We know from previous research that people with a poor prognosis have a that makes them have a more aggressive disease but we still need to understand at a cellular level what that gene defect does to the cells," she said.

"The cancer cells basically talk to surrounding cells in the so we want to know how they interact with the and how they're told to stay alive.

"Once we know how the cells communicate, we could look at developing a targeted drug therapy to stop the interaction, which would essentially prevent the from taking over."

With CLL typically diagnosed in older adults, Dr Thurgood said the disease was set to become more prevalent as the population ages.

"The fact we're living longer means the frequency of the disease is going to skyrocket because a lot more people will be diagnosed with it, therefore any new information will become crucial to prevention and treatment.

"Once we've refined our research methods and we know more about CLL we can apply our knowledge to other leukaemias, including the pathogenic childhood cancers."

Explore further: New potential treatment opportunities for leukemia patients

Related Stories

New potential treatment opportunities for leukemia patients

April 14, 2014
(Medical Xpress)—The long-term survival of people suffering from chronic lymphocytic leukemia (CLL) could be increased with the development of new therapeutic strategies.

Researchers develop new approach to chronic lymphocytic leukemia treatment

March 14, 2014
Dartmouth researchers have developed a novel and unique approach to treating Chronic Lymphocytic Leukemia (CLL), a form of blood cancer that often requires repeated chemotherapy treatments to which it grows resistant. The ...

Boosting immune responses against leukaemia

November 21, 2012
(Medical Xpress)—In the first of its kind, a translational study undertaken at the Malaghan Institute of Medical Research has revealed that boosting the activity of a rare type of immune cell could be an effective way to ...

People with leukaemia are more prone to infection – but not from one particular herpes virus

March 19, 2014
People with chronic lymphocytic leukaemia (CLL) are essentially more prone to infections such as varicella, influenza or pneumococci due to the reduction in the number of antibodies that their condition causes. Researchers ...

Leap in leukemia treatment reported by Dartmouth researchers

May 13, 2013
Doctors at Dartmouth-Hitchcock's Norris Cotton Cancer Center (NCCC) have found a combination of drugs to potentially treat chronic lymphocytic leukemia (CLL) more effectively. The research was published online on May 3, 2013, ...

Monoclonal antibody targets, kills leukemia cells

March 25, 2013
Researchers at the University of California, San Diego Moores Cancer Center have identified a humanized monoclonal antibody that targets and directly kills chronic lymphocytic leukemia (CLL) cells.

Recommended for you

Shooting the achilles heel of nervous system cancers

July 20, 2017
Virtually all cancer treatments used today also damage normal cells, causing the toxic side effects associated with cancer treatment. A cooperative research team led by researchers at Dartmouth's Norris Cotton Cancer Center ...

Molecular changes with age in normal breast tissue are linked to cancer-related changes

July 20, 2017
Several known factors are associated with a higher risk of breast cancer including increasing age, being overweight after menopause, alcohol intake, and family history. However, the underlying biologic mechanisms through ...

Immune-cell numbers predict response to combination immunotherapy in melanoma

July 20, 2017
Whether a melanoma patient will better respond to a single immunotherapy drug or two in combination depends on the abundance of certain white blood cells within their tumors, according to a new study conducted by UC San Francisco ...

Discovery could lead to better results for patients undergoing radiation

July 19, 2017
More than half of cancer patients undergo radiotherapy, in which high doses of radiation are aimed at diseased tissue to kill cancer cells. But due to a phenomenon known as radiation-induced bystander effect (RIBE), in which ...

Definitive genomic study reveals alterations driving most medulloblastoma brain tumors

July 19, 2017
The most comprehensive analysis yet of medulloblastoma has identified genomic changes responsible for more than 75 percent of the brain tumors, including two new suspected cancer genes that were found exclusively in the least ...

Novel CRISPR-Cas9 screening enables discovery of new targets to aid cancer immunotherapy

July 19, 2017
A novel screening method developed by a team at Dana-Farber/Boston Children's Cancer and Blood Disorders Center—using CRISPR-Cas9 genome editing technology to test the function of thousands of tumor genes in mice—has ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.